Stryker Company Leadership
SYK Stock | USD 357.44 1.27 0.35% |
About 92 percent of Stryker's insiders are activelly selling. The analysis of insiders' sentiment of trading Stryker stock suggests that many insiders are panicking at this time. Stryker employs about 52 K people. The company is managed by 43 executives with a total tenure of roughly 382 years, averaging almost 8.0 years of service per executive, having 1209.3 employees per reported executive.
Kevin Lobo Chairman Chairman of the Board, President, Chief Executive Officer |
William Parfet Chairman Non-Executive Independent Chairman of the Board |
Stryker's Insider Buying Vs Selling
8
Selling | Buying |
Latest Trades
2024-03-07 | William E Berry Jr | Disposed 7690 @ 358.48 | View | ||
2024-02-05 | Ronda E Stryker | Disposed 201146 @ 342.9 | View | ||
2024-02-02 | Allan C Golston | Disposed 3273 @ 341 | View | ||
2023-11-28 | William E Berry Jr | Disposed 573 @ 292.28 | View | ||
2023-11-17 | Kevin Lobo | Disposed 56483 @ 287.91 | View | ||
2023-11-16 | Srikant M Datar | Disposed 500 @ 291.92 | View | ||
2023-11-14 | Srikant M Datar | Disposed 750 @ 287.57 | View | ||
2023-10-24 | Greg Stanton | Disposed @ 265.06 | |||
2023-09-26 | Greg Stanton | Acquired @ 273.54 | |||
2023-09-06 | Viju Menon | Disposed 5000 @ 289 | View | ||
2023-06-01 | Srikant M Datar | Disposed 500 @ 278.5 | View | ||
2023-05-18 | Srikant M Datar | Disposed 1000 @ 286 | View |
Monitoring Stryker's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Stryker's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Stryker. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Stryker's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Stryker |
Stryker's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Stryker's future performance. Based on our forecasts, it is anticipated that Stryker will maintain a workforce of about 52000 employees by April 2024.Stryker's latest congressional trading
Congressional trading in companies like Stryker, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Stryker by those in governmental positions are based on the same information available to the general public.
2023-09-26 | Representative Greg Stanton | Acquired Under $15K | Verify | ||
2023-03-17 | Representative Michael C. Burgess | Disposed $15K to $50K | Verify | ||
2023-02-24 | Representative Thomas H. Kean | Disposed $15K to $50K | Verify | ||
2022-11-30 | Senator Daniel S Sullivan | Acquired Under $15K | Verify | ||
2022-11-30 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
2022-01-06 | Representative Rick Larsen | Acquired Under $15K | Verify | ||
2021-04-09 | Representative Sara Jacobs | Disposed $15K to $50K | Verify | ||
2020-09-16 | Representative Gilbert Cisneros | Acquired Under $15K | Verify | ||
2020-04-14 | Senator David A Perdue , Jr | Acquired Under $15K | Verify | ||
2020-04-14 | Senator David Perdue | Acquired Under $15K | Verify | ||
2019-12-31 | Representative Cynthia Axne | Acquired Under $15K | Verify | ||
2019-02-28 | Senator Jack Reed | Acquired Under $15K | Verify | ||
2017-08-24 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
2016-09-08 | Senator Susan M. Collins | Acquired $50K to $100K | Verify |
Stryker Management Team Effectiveness
The company has Return on Asset of 0.0687 % which means that on every $100 spent on assets, it made $0.0687 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1798 %, implying that it generated $0.1798 on every 100 dollars invested. Stryker's management efficiency ratios could be used to measure how well Stryker manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is expected to rise to 0.21 this year. Return On Assets is expected to rise to 0.11 this year. At this time, Stryker's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 41.9 B this year, although the value of Non Current Liabilities Other will most likely fall to about 1.8 B.Common Stock Shares Outstanding is expected to rise to about 426.3 M this year. Net Income Applicable To Common Shares is expected to rise to about 2.8 B this year
Stryker Workforce Comparison
Stryker is rated third in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 187,593. Stryker totals roughly 52,000 in number of employees claiming about 28% of equities under Health Care industry.
Stryker Profit Margins
The company has Net Profit Margin of 0.15 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.24 %, which entails that for every 100 dollars of revenue, it generated $0.24 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.5 | 0.637 |
|
| |||||
Net Profit Margin | 0.096 | 0.1544 |
|
| |||||
Operating Profit Margin | 0.14 | 0.1897 |
|
| |||||
Pretax Profit Margin | 0.13 | 0.1792 |
|
| |||||
Return On Assets | 0.11 | 0.0793 |
|
| |||||
Return On Equity | 0.19 | 0.1702 |
|
|
Stryker Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stryker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stryker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Stryker insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.871 | 27 | 31 | 354,106 | 1,421,346 |
2023-12-01 | 0.2692 | 7 | 26 | 198,416 | 385,449 |
2023-09-01 | 0.2 | 1 | 5 | 2,000 | 8,739 |
2023-06-01 | 1.0 | 14 | 14 | 10,550 | 225,022 |
2023-03-01 | 0.5455 | 36 | 66 | 345,350 | 1,250,084 |
2022-12-01 | 0.3158 | 6 | 19 | 199,369 | 395,988 |
2022-09-01 | 0.25 | 1 | 4 | 2,343 | 2,244 |
2022-06-01 | 0.8421 | 16 | 19 | 28,902 | 765,950 |
2022-03-01 | 1.25 | 25 | 20 | 417,297 | 97,723 |
2021-12-01 | 0.2045 | 9 | 44 | 19,897 | 353,176 |
2021-09-01 | 0.2857 | 2 | 7 | 5,659 | 725,526 |
2021-06-01 | 1.2105 | 23 | 19 | 145,604 | 255,379 |
2021-03-01 | 1.2 | 18 | 15 | 339,679 | 139,015 |
2020-12-01 | 0.3077 | 4 | 13 | 128,520 | 228,124 |
2020-09-01 | 0.5 | 4 | 8 | 32,567 | 200,987 |
2020-06-01 | 0.4857 | 17 | 35 | 41,562 | 89,036 |
2020-03-01 | 0.9286 | 26 | 28 | 458,663 | 779,602 |
2019-12-01 | 0.625 | 5 | 8 | 13,706 | 44,984 |
2019-09-01 | 0.4828 | 14 | 29 | 71,723 | 349,233 |
2019-06-01 | 1.0 | 20 | 20 | 36,305 | 63,969 |
2019-03-01 | 0.8 | 36 | 45 | 607,254 | 324,744 |
2018-12-01 | 0.3684 | 7 | 19 | 47,042 | 84,753 |
2018-09-01 | 1.2 | 6 | 5 | 49,487 | 76,332 |
2018-06-01 | 0.7647 | 13 | 17 | 12,908 | 75,419 |
2018-03-01 | 0.8103 | 47 | 58 | 699,630 | 348,088 |
2017-12-01 | 0.2727 | 3 | 11 | 46,551 | 114,139 |
2017-09-01 | 0.625 | 5 | 8 | 8,172 | 31,826 |
2017-06-01 | 0.5 | 18 | 36 | 393,330 | 720,492 |
2017-03-01 | 1.16 | 58 | 50 | 685,925 | 157,362 |
2016-12-01 | 0.0704 | 5 | 71 | 32,684 | 451,961 |
2016-09-01 | 0.0429 | 3 | 70 | 6,720 | 417,482 |
2016-06-01 | 0.098 | 10 | 102 | 133,995 | 770,179 |
2016-03-01 | 0.4472 | 55 | 123 | 748,537 | 741,629 |
2015-12-01 | 0.08 | 6 | 75 | 101,481 | 556,137 |
2015-09-01 | 0.0145 | 1 | 69 | 5,000 | 410,974 |
2015-06-01 | 0.2273 | 5 | 22 | 31,043 | 1,142,550 |
2015-03-01 | 1.26 | 63 | 50 | 634,149 | 600,207 |
2014-12-01 | 0.0682 | 3 | 44 | 32,151 | 327,200 |
2014-09-01 | 0.0385 | 1 | 26 | 12,000 | 185,000 |
2014-06-01 | 0.0313 | 1 | 32 | 8,618 | 203,142 |
2014-03-01 | 0.8182 | 45 | 55 | 496,980 | 275,763 |
2013-12-01 | 0.0323 | 2 | 62 | 48,950 | 491,978 |
2013-09-01 | 0.0513 | 2 | 39 | 24,000 | 281,853 |
2013-06-01 | 0.1143 | 4 | 35 | 143,956 | 326,134 |
2013-03-01 | 1.0286 | 36 | 35 | 486,613 | 160,018 |
2012-12-01 | 0.0714 | 2 | 28 | 13,801 | 244,000 |
2012-06-01 | 0.0313 | 1 | 32 | 10,000 | 289,000 |
2012-03-01 | 1.1379 | 33 | 29 | 303,981 | 215,132 |
2011-06-01 | 0.1585 | 13 | 82 | 443,418 | 1,575,037 |
2011-03-01 | 0.6222 | 28 | 45 | 518,512 | 452,560 |
2010-12-01 | 0.1667 | 1 | 6 | 2,000 | 340,000 |
2010-03-01 | 0.8333 | 25 | 30 | 739,758 | 898,375 |
2009-09-01 | 0.16 | 4 | 25 | 17,330 | 2,010,500 |
2009-06-01 | 0.5 | 4 | 8 | 21,750 | 280,000 |
2009-03-01 | 7.5 | 15 | 2 | 606,875 | 40,000 |
2008-09-01 | 0.2381 | 5 | 21 | 107,000 | 609,151 |
2008-03-01 | 0.2564 | 10 | 39 | 302,850 | 1,254,326 |
2007-12-01 | 0.1538 | 6 | 39 | 196,000 | 1,235,115 |
2007-09-01 | 0.0256 | 1 | 39 | 1,000.00 | 750,000 |
2005-12-01 | 1.0 | 1 | 1 | 5,000 | 525.00 |
2005-06-01 | 0.7273 | 8 | 11 | 367,000 | 940,000 |
2004-09-01 | 0.5 | 1 | 2 | 2,500 | 265,555 |
2004-03-01 | 0.9 | 9 | 10 | 133,600 | 232,893 |
2003-12-01 | 0.65 | 13 | 20 | 466,000 | 727,034 |
2003-09-01 | 0.25 | 2 | 8 | 93,034 | 425,034 |
Stryker Notable Stakeholders
A Stryker stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Stryker often face trade-offs trying to please all of them. Stryker's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Stryker's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kevin Lobo | Chairman of the Board, President, Chief Executive Officer | Profile | |
William Parfet | Non-Executive Independent Chairman of the Board | Profile | |
Fink | Vice President Global Human Resources | Profile | |
William Berry | Principal Accounting Officer, Vice President, Corporate Controller | Profile | |
Katherine Owen | Vice President - Strategy and Investor Relations | Profile | |
Graham Mclean | President Asia-Pacific | Profile | |
David Floyd | Group President of Orthopaedics | Profile | |
Yin Becker | Vice President - Communications, Public Affairs and Corporate Marketing | Profile | |
Timothy Scannell | Group President of Medsurg and Neurotechnology | Profile | |
Robert Fletcher | Vice President Chief Legal Officer | Profile | |
Glenn Boehnlein | Chief Financial Officer, Vice President | Profile | |
Viju Menon | Group President - Global Quality and Business Operations | Profile | |
Lonny Carpenter | Group President - Global Quality and Operations | Profile | |
Bijoy Sagar | Chief Digital Technology Officer, Vice President | Profile | |
Bronwen Taylor | Vice President - Compliance and Risk Management | Profile | |
Steven Benscoter | Vice President - Human Resources | Profile | |
Kathryn Fink | Chief Human Resource Officer, Vice President | Profile | |
Scott Bruder | Vice President Chief Medical and Scientific Officer | Profile | |
William Jellison | CFO and VP | Profile | |
Andrew Silvernail | Independent Director | Profile | |
Sherilyn McCoy | Independent Director | Profile | |
Ronda Stryker | Independent Director | Profile | |
Allan Golston | Lead Independent Director | Profile | |
Louise Francesconi | Independent Director | Profile | |
Giovanni Caforio | Independent Director | Profile | |
Roch Doliveux | Independent Director | Profile | |
Rajeev Suri | Independent Director | Profile | |
Mary Brainerd | Independent Director | Profile | |
Srikant Datar | Independent Director | Profile | |
Howard Cox | Independent Director | Profile | |
Dean Bergy | VP and Corporate Secretary | Profile | |
Lisa Tatum | Independent Director | Profile | |
Robert Cohen | CTO Replacement | Profile | |
Preston Wells | Vice President - Investor Relations | Profile | |
Curtis Hall | Chief Legal Officer | Profile | |
Ramesh Subrahmanian | Advisor | Profile | |
Spencer Stiles | Group President Orthopaedics and Spine | Profile | |
Andrew Pierce | Group Neurotechnology | Profile | |
Jason Beach | Vice Relations | Profile | |
M Fink | Chief Human Resource Officer, Vice President | Profile | |
Alan Douville | Chief VP | Profile | |
J Pierce | Group President MedSurg and Neurotechnology | Profile | |
Michael Hutchinson | General Counsel | Profile |
About Stryker Management Performance
The success or failure of an entity such as Stryker often depends on how effective the management is. Stryker management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Stryker management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Stryker management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for 2024 | ||
Return On Capital Employed | 0.12 | 0.21 | |
Return On Assets | 0.08 | 0.11 | |
Return On Equity | 0.17 | 0.19 |
The data published in Stryker's official financial statements usually reflect Stryker's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Stryker. For example, before you start analyzing numbers published by Stryker accountants, it's critical to develop an understanding of what Stryker's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Stryker's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Stryker's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Stryker's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Stryker. Please utilize our Beneish M Score to check the likelihood of Stryker's management manipulating its earnings.
Stryker Workforce Analysis
Traditionally, organizations such as Stryker use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Stryker within its industry.Stryker Manpower Efficiency
Return on Stryker Manpower
Revenue Per Employee | 394.2K | |
Revenue Per Executive | 476.7M | |
Net Income Per Employee | 60.9K | |
Net Income Per Executive | 73.6M | |
Working Capital Per Employee | 88.4K | |
Working Capital Per Executive | 106.9M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Stryker Stock analysis
When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.027 | Dividend Share 3.05 | Earnings Share 8.23 | Revenue Per Share 53.999 | Quarterly Revenue Growth 0.118 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.